Quantitative digital imaging analysis of HER2 immunohistochemistry predicts the response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma.

Aidan C LiJing ZhaoChao ZhaoZhongliang MaRamon HartageYunxiang ZhangXiaoxian LiAnil V Parwani

Published in: Breast cancer research and treatment (2020)

HER2 IHC DIA connectivity is the most important factor predicting pCR to anti-HER2 neoadjuvant chemotherapy in patients with HER2-positive breast cancer.

Keyphrases

neoadjuvant chemotherapy
positive breast cancer
locally advanced
lymph node
sentinel lymph node
high resolution
rectal cancer
squamous cell carcinoma
resting state
functional connectivity
early stage
real time pcr